p53-independent induction of apoptosis by cyclin-dependent kinase inhibition. 1996

Y Shibata, and S Nishimura, and A Okuyama, and T Nakamura
Department of Radiology, Nagasaki University, School of Dentistry, Japan.

The G1 checkpoint and terminal differentiation may be associated with apoptosis, the induction of which is in large part dependent on the presence of active p53. However, cells lacking wild-type p53 can undergo apoptotic cell death during normal development and during terminal differentiation of malignant cells. Using the specific inhibitor for cyclin-dependent kinases (cdks), we show here that an inhibition of cdk activity per se can induce apoptotic cell death during G1-S transition of the cell cycle in a p53-independent manner. The apoptotic process triggered by cdk inhibition was associated with an overriding of the G1-S boundary and was inhibited by arresting the cells in G1. These results raise the possibility that aberrant cell cycle machinery may result in self-elimination, even in the absence of p53, and further indicate that cdk activity is not necessarily required during this process.

UI MeSH Term Description Entries
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D005786 Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation. Gene Action Regulation,Regulation of Gene Expression,Expression Regulation, Gene,Regulation, Gene Action,Regulation, Gene Expression
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015107 4-Butyrolactone One of the FURANS with a carbonyl thereby forming a cyclic lactone. It is an endogenous compound made from gamma-aminobutyrate and is the precursor of gamma-hydroxybutyrate. It is also used as a pharmacological agent and solvent. 1,4-Butanolide,4-Hydroxybutyric Acid Lactone,Furanone, tetrahydro-2-,gamma-Butyrolactone,Dihydro-2(3H)-furanone,1,4 Butanolide,4 Butyrolactone,4 Hydroxybutyric Acid Lactone,Furanone, tetrahydro 2,Lactone, 4-Hydroxybutyric Acid,gamma Butyrolactone
D016159 Tumor Suppressor Protein p53 Nuclear phosphoprotein encoded by the p53 gene (GENES, P53) whose normal function is to control CELL PROLIFERATION and APOPTOSIS. A mutant or absent p53 protein has been found in LEUKEMIA; OSTEOSARCOMA; LUNG CANCER; and COLORECTAL CANCER. p53 Tumor Suppressor Protein,Cellular Tumor Antigen p53,Oncoprotein p53,TP53 Protein,TRP53 Protein,p53 Antigen,pp53 Phosphoprotein,Phosphoprotein, pp53
D017209 Apoptosis A regulated cell death mechanism characterized by distinctive morphologic changes in the nucleus and cytoplasm, including the endonucleolytic cleavage of genomic DNA, at regularly spaced, internucleosomal sites, i.e., DNA FRAGMENTATION. It is genetically programmed and serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth. Apoptosis, Extrinsic Pathway,Apoptosis, Intrinsic Pathway,Caspase-Dependent Apoptosis,Classic Apoptosis,Classical Apoptosis,Programmed Cell Death,Programmed Cell Death, Type I,Apoptoses, Extrinsic Pathway,Apoptoses, Intrinsic Pathway,Apoptosis, Caspase-Dependent,Apoptosis, Classic,Apoptosis, Classical,Caspase Dependent Apoptosis,Cell Death, Programmed,Classic Apoptoses,Extrinsic Pathway Apoptoses,Extrinsic Pathway Apoptosis,Intrinsic Pathway Apoptoses,Intrinsic Pathway Apoptosis
D018844 Cyclin-Dependent Kinases Protein kinases that control cell cycle progression in all eukaryotes and require physical association with CYCLINS to achieve full enzymatic activity. Cyclin-dependent kinases are regulated by phosphorylation and dephosphorylation events. Cyclin-Dependent Kinase,Cyclin-Dependent Protein Kinase,cdk Proteins,Cyclin-Dependent Protein Kinases,Cyclin Dependent Kinase,Cyclin Dependent Kinases,Cyclin Dependent Protein Kinase,Cyclin Dependent Protein Kinases,Kinase, Cyclin-Dependent,Kinase, Cyclin-Dependent Protein,Protein Kinase, Cyclin-Dependent

Related Publications

Y Shibata, and S Nishimura, and A Okuyama, and T Nakamura
October 2000, Antimicrobial agents and chemotherapy,
Y Shibata, and S Nishimura, and A Okuyama, and T Nakamura
July 2017, Molecular and cellular biology,
Y Shibata, and S Nishimura, and A Okuyama, and T Nakamura
June 2012, Mini reviews in medicinal chemistry,
Y Shibata, and S Nishimura, and A Okuyama, and T Nakamura
August 2017, Oncotarget,
Y Shibata, and S Nishimura, and A Okuyama, and T Nakamura
December 2018, Journal of cellular biochemistry,
Y Shibata, and S Nishimura, and A Okuyama, and T Nakamura
November 2010, The Journal of urology,
Y Shibata, and S Nishimura, and A Okuyama, and T Nakamura
January 2019, Frontiers in pharmacology,
Y Shibata, and S Nishimura, and A Okuyama, and T Nakamura
October 1995, The American journal of pathology,
Y Shibata, and S Nishimura, and A Okuyama, and T Nakamura
May 1997, The Journal of biological chemistry,
Copied contents to your clipboard!